Biotech Co. Gets Investor Suit Over Failed COVID Test Tossed

By Katryna Perera · December 12, 2022, 6:25 PM EST

A biotech company that was sued by investors over issues with its COVID-19 test rollout convinced a California federal judge to toss the suit after arguing that none of the statements identified...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

IN RE Talis Biomedical Securities Litigation

Case Number

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2022

Recent Articles By Katryna

December 05, 2024
FINRA Fines Firm $900K Over SPAC Underwriting Fee Issues
November 04, 2024
Late New Evidence Can't Revive Investor Suit, Judge Says
October 31, 2024
Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand
October 28, 2024
SEC Sues To Enforce Subpoena On Telehealth Co.
September 27, 2024
Pharma Co. Amarin Beats Class Action Over Patent Issues
September 26, 2024
Healthcare REIT Defeats Investor Suit For Good
September 23, 2024
Mallinckrodt Brass Can't Avoid Investor Suit Over 2nd Ch. 11
September 23, 2024
SEC Scores $12M Judgment In Unregistered Dealer Case
September 05, 2024
Pharma Co. Verrica Fails To Shed Investor Suit Over FDA OK
August 21, 2024
Health Co. Investors Fight To Keep Suit Over Migrant Deal